The Big Heart Disease Lie

Home Treatment of Cardiovascular Disease

Get Instant Access

1. Obraztsov VP, Strazhesko ND. The symptomatology and diagnosis of coronary thrombosis. In: Vorobeva VA, Konchalovski MP, eds. Works of First Congress of Russian Therapists. Comradeship Typography of A.E. Mamontov, Moscow, 1910, pp. 26-43.

2. Sproul J. A general practitioner's views on the treatment of angina pectoris. N Engl J Med 1936;215: 443-452.

3. Phipps C. Contributory causes of coronary thrombosis. JAMA 1936;106:761-762.

4. Master AM. The role of effort and occupation (including physicians) in coronary occlusion. JAMA 1960;174:942-948.

5. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996;94: 2013-2020.

6. Fuster V Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-2146.

7. Falk E, Shah PK, Fuster V Coronary plaque disruption. Circulation 1995;92:657-671.

8. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995;91:2844-2850.

9. Falk E. Why do plaques rupture? Circulation 1992;86(Suppl. III):III-30-III-42.

10. Schroeder AP, Falk E. Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin 1996;14:211-220.

11. Shah PK. Plaque disruption and thrombosis. Cardiol Rev 2000;8:31-39.

12. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104: 365-372.

13. Davies MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-1140.

14. Myerburg RJ, Kessler KM, Castellanos A. Pathophysiology of sudden cardiac death. Pacing Clin Elec-trophysiol 1991;14:935-943.

15. Little WL, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-1166.

16. Little WL, Applegate RJ. The role of plaque size and degree of stenosis in acute myocardial infarction. Cardiol Clin 1996;14:221-228.

17. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101:2149-2153.

18. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-1772.

19. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.

20. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-4103.

21. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000;321:208-213.

22. Humphries SE, Talmud PJ, Hawe E, Bolla M, Day INM, Miller GJ. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001;358:115-119.

23. Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the Factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000;343:774-780.

24. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322.

25. Willich SN, Linderer T, Wegschieder K, Leizorovicz A, Alamercery I, Schroeder R. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. Circulation 1989;80:853-858.

26. Gnecchi-Ruscone T, Piccaluga E, Guzetti S, Contini M, Montano N, Nicolis E. Morning and Monday: critical periods for the onset of acute myocardial infarction. The GISSI 2 study experience. Eur Heart J 1994;15:882-887.

27. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Morning peak in the incidence of myoardial infarction: experience in the ISIS-2 trial. Eur Heart J 1992;13:594-598.

28. Marchant B, Ranjadayalan K, Stevenson R, Wilkinson P, Timmis AD. Circadian and seasonal factors in the pathogenesis of acute myocardial infarction: the influence of environmental temperature. Br Heart J 1993;69:385-387.

29. Thompson DR, Sutton TW, Jowett NI, Pohl JE. Circadian variation in the onset of chest pain in acute myocardial infarction. Br Heart J 1991;65:177-178.

30. Zornosa J, Smith M, Little W. Effect of activity on circadian variation in time of onset of acute myocardial infarction. Am J Cardiol 1992;69:1089-1090.

31. Hansen O, Johansson BW, Gullberg B. Circadian distribution of onset of acute myocardial infarction in subgroups from analysis of 10,791 patient treated in a single center. Am J Cardiol 1992;69:1003-1008.

32. Behar S, Halabi M, Reicher-Reiss H, et al. Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med 1993;94:395-400.

33. Van der Palen J, Doggen CJ, Beaglehole R. Variation in the time and day of onset of myocardial infarction and sudden death. N Z Med J 1995;108:332-334.

34. Spielberg C, Falkenhahn D, Willich SN, Wegscheider K, Voller H. Circadian, day-of-week, and seasonal variability in myocardial infarction: comparison between working and retired patients. Am Heart J 1996;132:579-585.

35. Tofler GH, Muller JE, Stone PH, et al. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol 1992;20:1049-1055.

36. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997;79:1512-1516.

37. Cannon CP, McCabe CH, Stone PH, et al. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am J Cardiol 1997;79: 253-258.

38. Behar S, Reicher-Reiss H, Goldbourt U, Kaplinsky E. Circadian variation in pain onset in unstable angina pectoris. Am J Cardiol 1991;67:91-93.

39. Beamer AD, Lee TH, Cook EF, et al. Diagnostic implications for myocardial ischemia of the circadian variation of the onset of chest pain. Am J Cardiol 1987;60:998-1002.

40. Figueras J, Lidon RM. Circadian rhythm of angina in patients with unstable angina: relationship with extent of coronary artery disease, coronary reserve, and ECG changes during pain. Eur Heart J 1994; 15:753-760.

41. Kleiman NS, Schechtman KB, Young PB, et al. Lack of diurnal variation in the onset of non-Q wave infarction. Circulation 1990;81:548-555.

42. Krantz DS, Kop WJ, Gabbay FH, et al. Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component. Circulation 1996;93: 1364-1371.

43. Mulcahy D, Dakak N, Zalos G, et al. Patterns and behavior of transient myocardial ischemia in stable coronary disease are the same in both men and women. A comparative study. J Am Coll Cardiol 1996;27:1629-1636.

44. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischemic burden and its alteration with anti-anginal agents. Lancet 1988;2:755-759.

45. Taylor CR, Hodge EM, White DA. Circadian rhythm of angina: similarity to circadian rhythms of myocardial infarction, ischemic ST segment depression, and sudden cardiac death. The Amlodipine Angina Study Group. Am Heart J 1989;118:1098-1099.

46. Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400.

47. Hausmann D, Nikutta P, Trappe HJ, Daniel WG, Wenzlaff P, Lichtlen PR. Circadian distribution of the characteristics of ischemic episodes in patients with stable coronary artery disease. Am J Cardiol 1990; 66:668-672.

48. Willich SN. European survey on circadian variation of angina pectoris (ESCVA): design and preliminary results. J Cardiovasc Pharmacol 1999;34(Suppl. 2):S9-S13.

49. Mickley H, Pless P, Nielsen JR, Moller M. Circadian variation of transient myocardial ischemia in the early out-of-hospital period after first acute myocardial infarction. Am J Cardiol 1991;67: 927-932.

50. Argentino C, Toni D, Rasura M, et al. Circadian variation in the frequency of ischemic stroke. Stroke 1990;21:387-389.

51. Marler JR, Price TR, Clark GL, et al. Morning increase in the onset of ischemic stroke. Stroke 1989; 20:473-476.

52. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study. Am J Cardiol 1987;60:801-806.

53. Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-138.

54. Moser DK, Stevenson WG, Woo MA, Stevenson LW. Timing of sudden death in patients with heart failure. J Am Coll Cardiol 1994;24:963-967.

55. Peters RW, Mitchell LB, Brooks MM, et al. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide, or moricizine in the Cardiac Arrhythmia Supression Trial (CAST). J Am Coll Cardiol 1994;23:283-289.

56. Mallavarapu C, Pancholy S, Schwartzman D, et al. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts. Am J Cardiol 1995;75:1140-1144.

57. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994;90:241-247.

58. Behrens S, Galecka M, Bruggemann T, et al. Circadian variation of sustained ventricular tach-yarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator. Am Heart J 1995;130:79-84.

59. Auricchio A, Klein H. Circadian variations of ventricular tachyarrhythmias detected by the implantable cardioverter-defibrillator. G Ital Cardiol 1997;27:113-122.

60. Englund A, Behrens S, Wegscheider, Rowland E. Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter-defibrillator implantation. J Am Coll Cardiol 1999;34:1560-1568.

61. Grimm W, Menz WM, Hoffman J, Maisch B. Circadian variation and onset mechanisms of ventricular tachyarrhythmias in patients with coronary disease versus idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 2000;23:1939-1943.

62. Arntz HR, Willich SN, Oeff M, et al. Circadian variation of sudden cardiac death reflects age related variability in ventricular fibrillation. Circulation 1993;88:2284-2289.

63. Willich SN, Lowel H, Lewis M, et al. Association of wake time and the onset of myocardial infarction. Triggers and mechanisms of myocardial infarction (TRIMM) pilot study. Circulation 1991;84 (Suppl. 6):V162-V167.

64. Goldberg RJ, Brady P, Muller JE, et al. Time of onset of symptoms of acute myocardial infarction. Am J Cardiol 1990;60:140-144.

65. Peters RW, Zoble RG, Liebson PR, Pawitan Y, Brooks MM, Proschan M. Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Supression Trial (CAST) experience. J Am Coll Cardiol 1993;22:998-1003.

66. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65-68.

67. Barry J, Campbell S, Yeung AC, Raby KE, Selwyn AP. Waking and rising at night as a trigger of myocardial ischemia. Am J Cardiol 1991;67:1067-1072.

68. Willich SN, Lowel H, Lewis M, Hormann A, Anrtz HR, Keil U. Weekly variation of acute myocardial infarction. Increased Monday risk in the working population. Circulation 1994;90:87-93.

69. Sayer JW, Wilkinson P, Ranjadalayan K, Ray S, Marchant B, Timmis AD. Attenuation or absence of circadian and seasonal rhythm of acute myocardial infarction. Heart 1997;77:325-329.

70. Thompson DR, Pohl JE, Tse YY, Hiorns RW. Meteorological factors and the time of onset of chest pain in acute myocardial infarction. Int J Biometeorol 1996 39:116-120.

71. Couch RD. Travel, time zones, and sudden cardiac death. Am J Forensic Med 1990;11:106-111.

72. Hirasawa K, Tateda K, Shibata J, Yokoyama K. Multivariate analysis of meteorological factors and evaluation of circadian rhythm: their relation to the occurrence of acute myocardial infarction. J Cardiol 1990;20:797-805.

73. Baker-Blocker A. Winter weather and cardiovascular mortality in Minneapolis-St. Paul, Am J Public Health 1982;72:261-265.

74. Anderson TW, Rochard C. Cold snaps, snowfall, and sudden death from ischemic heart disease. Can Med Assoc J 1979;121:1580-1583.

75. Danet S, Richard F, Montaye M, et al. Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular disease). Circulation 1999;100:E1-E7.

76. Fries RP, Heisel AG, Jung JK, Schieffer HJ. Circannual variation of malignant ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators and either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1194-1197.

77. Spencer FA, Goldberg RJ, Becker RC, Gore JM. Seasonal distribution of acute myocardial infarction in the Second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998;31:1226-1233.

78. Ku CS, Yang CY, Lee WJ, Chiang HT, Liu CP, Lin SL. Absence of a seasonal variation in myocardial infarction onset in a region without temperature extremes. Cardiology 1998;89:277-282.

79. Fava S, Azzopardi J, Muscat HA, Fenech FF. Absence of circadian variation in the onset of acute myocardial infarction in diabetic subjects. Br Heart J 1995;74:370-372.

80. Hjalmarson A, Gilpin EA, Nicod P, et al. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation 1989;80:267-275.

81. Tanaka T, Fujita M, Fudo T, Tamaki S, Nohara R, Sasayama S. Modification of the circadian variation of symptom onset of acute myocardial infarction in diabetes mellitus. Coron Artery Dis 1995;6: 241-244.

82. Toiler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol 1990;66:22-27.

83. Sumiyoshi T, Haze K, Saito M, Fukami K, Goto Y, Hiramori K. Evaluation of clinical factors involved in onset of myocardial infarction. Jpn Circ J (Japan) 1986;50:164-173.

84. Smith M, Little WC. Potential precipitating factors of the onset of myocardial infarction, Am J Med Sci 1992;303:141-144.

85. Stewart RA, Robertson MC, Wilkins GT, Low CJ, Restieaux NJ. Association between activity at onset of symptoms and outcome of acute myocardial infarction. J Am Coll Cardiol 1997;29:250-253.

86. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-153.

87. Willich SN, Lewis M, Lowel H, Arntz R, Schubert F, Schroeder R. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 1993;329:1684-1690.

88. Mittleman A, Maclure M, Toiler GH, Sherwood JB, Goldberg RJ, Muller JE . Triggering of myocar-dial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 1993;329:1677-1683.

89. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984;311:874-877.

90. Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 1996;28:428-431.

91. Albert CM, Mittleman MA, Chae CU, Min-Lee I, Hennekens CH, Manson JoAnn E. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000;343:1355-1361.

92. Nalbangtil I, Yigthbasi O, Kiliccioglu B. Sudden death in sexual activity. Am Heart J 1976;91: 405-406.

93. Ueno M. The so-called coition death. Jpn J Leg Med 1963;17:330-340.

94. Muller JE, Mittleman MA, Maclure M, Sherwood JB, Toiler GH, for the Determinants of Myocardial Infarction Onset Study Investigators. Triggering of myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. JAMA 1996;275:1405-1409.

95. Cottington EM Matthews KA, Talbott EM, Kuller LH. Environmental events preceeding sudden death in women. Psychosom Med 1980;42:567-575.

96. Parkes CM, Benjamin B, Fitzgerald RG. Broken heart: a statistical study of increased mortality among widowers. Br Med J 1969;1:740-743.

97. Kark JD, Goldman S, Epstein L. Iraqi missle attacks on Israel. The association of mortality with a threatening stressor. JAMA 1995; 273:1208-1210.

98. Trichopoulos D, Katsouyanni K, Zavitsanos X, Tzonou A, Dalla-Vorgia P. Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experiment. Lancet 1983;1:441-444.

99. Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K. Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: possible triggering of cardiovascular events after a major earthquake. J Am Coll Cardiol 1997;29:926-933.

100. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996; 334:413-419.

101. Julkunen J, Idanpaan-Heikkila U, Saarinen T. Components of Type A behavior and the first year prognosis of a myocardial infarction. J Psychosom Res 1993;37:11-18.

102. Jiang W, Babyak M, Krantz DS, et al. Mental stress induced myocardial ischemia and cardiac events. JAMA 1996;275:1651-1656.

103. Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation 1995; 92:1720-1725.

104. Mittleman MA, Maclure M, Nachnani M, Sherwood JB, Muller JE. Educational attainment, anger, and the risk of triggering myocardial infarction onset. The Determinants of Myocardial Infarction Onset Study Investigators. Arch Intern Med 1997;157:769-775.

105. Mittleman MA, Mintzer D, Maclure M, Tofler GH, Sherwood J, Muller JE. Triggering myocardial infarction by cocaine. Circulation 1999;99:2737-2741.

106. Mittleman MA, Lewis RA, Maclure M, Sherwood J, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001;103:2305-2309.

107. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001;103:2810-2815.

108. Brown DL. Disparate effects of the 1989 Loma Prieta and 1994 Northridge earthquakes on hospital admissions for acute myocardial infarction: importance of superimposition of triggers. Am Heart J 1999;137:830-836.

109. Tsuda M, Hayashi H, Kanematsu K, Yoshikane M, Saito H, Comparison between diurnal distribution of onset of infarction in patients with acute myocardial infarction and circadian variation of blood presure in patients with coronary artery disease. Clin Cardiol 1993;16:543-547.

110. Kawano Y, Tochikubo O, Minamisawa K, Miyajima E, Ishii M. Circadian variation of hemodynamics in patients with essential hypertension: comparison between early morning and evening. J Hypertens 1994;12:1405-1412.

111. Deedwania PC. Hemodynamic changes as triggers of cardiovascular events. Cardiol Clin 1996;14: 229-238.

112. Saito D, Matsubara K, Yamanari H, et al. Morning increase in hemodynamic response to exercise in patients with angina pectoris. Heart Vessels 1993;8:149-154.

113. Quyyumi AA, Panza JA, Diodati JG, Lakatos E, Epstein SE. Circadian variation in ischemic threshold. A mechanism underlying the circadian variation in ischemic events. Circulation 1992;86:22-28.

114. Shaw JA, Chin-Dusting JPF, Kingwell BA, Dart AM. Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 2001;103:806-812.

115. El-Tamimi H, Mansour M, Pepine CJ, Wargovich TJ, Chen H. Circadian variation in coronary tone in patients with stable angina. Circulation 1995;92:3201-3205.

116. Aranha Rosito GB, Tofler GH. Hemostatic factors as triggers of cardiovascular events. Cardiol Clin 1996;14:239-250.

117. Brezinski DA, Tofler GH, Muller JE, et al. Morning increase in platelet aggregability: association with assumption of the upright posture. Circulation 1988;78:35-40.

118. Tofler GH, Brezinski DA, Schaefer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden death. N Engl J Med 1987;316:1514-1518.

119. Willich SN, Arntz HR, Lowel H, Lewis M, Schroeder R. Wake up time, thrombocyte aggregation, and the risk of acute coronary heart disease. The TRIMM (Trigger and Mechanisms of Myocardial Infarct) Study Group. Z Kardiol 1992;81(Suppl. 2):95-99.

120. Ehrly AM, Jung G. Circadian rhythm of human blood viscosity. Biorheology 1973;10:577-583.

121. Petralito A, Mangiafico RA, Gibilino S, Cuffari MA, Miano MF, Fiore CP. Daily modifications of plasma fibrinogen, platelet aggregation, Howell's time, PTT, TT, and antithrombin III in normal subjects and in patients with vascular disease. Chronobiologica 1982;9:195-201.

122. Bridges AB, Scott NA, McNeill GP, Pringle TH, Belch JJF. Circadian variation of white blood cell aggregation and free radical indices in men with ischemic heart disease. Eur Heart J 1992;13:1632-1636.

123. Bremner WF, Sothern RB, Kanabrocki EL, et al. Relation between circadian patterns in levels of circulating lipoprotein (a), fibrinogen, platelets, and lipid variables in men. Am Heart J 2000;139:164-173.

124. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-106.

125. Bridges AB, McLaren M, Saniabadi A, Fisher TC, Belch JJF. Circadian variation of endothelial cell function, red blood cell deformity, and dehydrothromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis 1991;2:447-452.

126. Andreotti F, Davies GJ, Hackett DR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death, and stroke. Am J Car-diol 1988;62:635-637.

127. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJ. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischemic heart disease. Br Heart J 1993;69:121-124.

128. Sayer JW, Gutteridge C, Syndercombe-Court D, Wilkinson P, Timmis AD. Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1998;32:1962-1968.

129. Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1 + 2, and plasmin-plasmin inhibitor complex. Circulation 1997;96:19-21.

130. Fujino T, Katou J, Fujita M, et al. Relationship between serum lipoprotein(a) level and thrombin generation to the circadian variation in the onset of acute myocardial infarction. Atherosclerosis 2001;155: 171-178.

131. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrin Metab 1985;60:1210-1215.

132. Stene M, Panagiotis N, Tuck MI, Sowers JR, Mayes D, Berg G. Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration, and circadian changes in normal man. J Clin Endocrin Metab 1980;51:1340-1345.

133. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to alpha-sympatheric vasoconstrictor activity. N Engl J Med 1991;325:986-990.

134. Furlan R, Guzzetti S, Crivellaro W, et al. Continuous 24 hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537-547.

135. Burr R, Hamilton P, Cowan M, et al. Nycthemeral profile of nonspectral heart rate variability measures in women and men. Description of a normal sample and two sudden cardiac arrest subsamples. J Electrocardiol 1994;27(Suppl.):54-62.

136. Marchant B, Stevenson R, Vaishnav S, Wilkinson P, Ranjadayalan K, Timmis AD. Influence of the autonomic nervous system on circadian patterns of myocardial ischemia: comparison of stable angina with the early post infarction period. Br Heart J 1994;71:329-333.

137. Klingenheben T, Rapp U, Hohnloser SH. Circadian variation of heart rate variability in postinfarction patients with and without life-threatening ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 1995;6:357-364.

138. Lombardi F, Sandrone G, Mortara A, et al. Circadian variation of spectral indices of heart rate variability after myocardial infarction. Am Heart J 1992;123:1521-1529.

139. Malik M, Farrell T, Camm AJ. Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. Am J Cardiol 1990;66: 1049-1054.

140. Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, Nesto RW. Effect of autonomic nervous system dysfunction of the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol 1994;24:956-960.

141. Kong TQ Jr, Goldberger JJ, Parker M, Wang T, Kadish AH. Circadian variation in human ventricular refractoriness. Circulation 1995;92:1507-1516.

142. Ong JJC, Sarma JSM, Venkataraman K, Levin SK, Singh BN. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J 1993;125:744-752.

143. Ishida S, Nakagawa M, Fujino T, Yonemochi H, Saikawa T, Ito M. Circadian variation of QT interval dispersion: correlation with heart rate variability. J Electrocardiol 1997;30:205-210.

144. Molnar J, Rosenthal JE, Weiss JS, Somberg JC. QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in twenty-four hour assessment. Am J Cardiol 1997;79:1190-1193.

145. Muller JE, Toiler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743.

146. Mittleman MA, Sisovick DS. Physical exertion as a trigger of myocardial infarction and sudden cardiac death. Cardiol Clin 1996;14:263-270.

147. Badimon I, Martinez-Gonzalez J, Royo T, Lassila R, Badimon JJ. A sudden increase in plasma epi-nephrine levels transiently enhances platelet deposition of severely damaged arterial wall-studies in a porcine model. Thromb Hemost 1999;82:1736-1742.

148. Roux F, D'Ambrosio C, Mohsenin V Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000;108:396-402.

149. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year followup in obstructive sleep apnea patients. Chest 1990;97:27-32.

150. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999;92:79-84.

151. Seppala T, Partinen M, Penttila A, Aspholm R, Tiainen E, Kaukianen A. Sudden death and sleeping history among Finnish men. J Intern Med 1991;229:23-38.

152. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Resp Crit Care Med 2000;162:81-86.

153. Aboyans V Cassat C, Lacroix P, et al. Is the morning peak of acute myocardial infarction's onset due to sleep related breathing disorders? A prospective study. Cardiology 2000;94:188-192.

154. Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in pateints with obstructive sleep apnoea syndrome. Eur Respir J 2000;16:648-652.

155. Nobili L, Schiavi G, Bozano E, De Carli F, Ferrillo F, Nobili F. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 2000;22:21-27.

156. Schefer H, Koehler U, Ploch T, Peter JH. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997;111:387-393.

157. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 1995;345: 1085-1087.

158. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnea and the effectiveness of continuous positive airway pressure: a systematic review of the reserach evidence. BMJ 1997;314:851-860.

159. Woods KL, Fletcher S, Jagger C. Modification of the circadian rhythm of onset of acute myocardial infarction by long term antianginal treatment. Br Heart J 1992;68:458-461.

160. Behrens S, Ehlers C, Bruggeman T, et al. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy. Clin Cardiol 1997;20:253-257.

161. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propanolol and the morning increase in the frequency of sudden cardiac death (BHAT study). Am J Cardiol 1989;63:1518-1520.

162. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study. Circulation 1994;90: 762-768.

163. Von Arnim T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis Results of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up. J Am Coll Cardiol 1996;28:20-24.

164. Andersen L, Sigurd B, Hansen J. Verapamil and circadian variation of sudden cardiac death. Am Heart J 1996;131:409-410.

165. Vaughn D, Jean-Lucien R, Ridker P, et al. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior infarction. Circulation 1997;96:442-448.

166. Mancini GB, Henry GC, Macaya C, et al. Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Revensing Endothelial Dysfunction) Study. Circulation 1996;94:258-265.

167. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.

168. Navalkar S, Parthasarathy S, Santanam N, Khan BV Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis. J Am Coll Cardiol 2001;37:440-444.

169. Ridker P, Manson JE, Buring J, Muller JE, Hennekens CH. Circadian variation of acute myocardial infarction and the effect of low dose aspirin in a randomized trial of physicians. Circulation 1990;82: 897-902.

170. Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 1995; 91:1341-1346.

171. Kono T, Morita H, Nishina T, et al. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol 1996;27:774-778.

172. Fujita M, Araie E, Yamanishi K, Miwa K, Kida M, Nakajima H. Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction. Am J Cardiol 1993;71:1369-1371.

173. Egstrup K. Attenuation of circadian variation by combined antianginal therapy with supression of morning and evening increases in transient myocardial ischemia. Am Heart J 1991;122:648-655.

174. Andrews TC, Fenton T, Toyosaki N, et al. Subsets of ambulatory myocardial ischemia based on heart rate activity: circadian distribution and response to anti-ischemic medication. Circulation 1993;88:92-100.

175. Deanfield JE, Detry JM, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double blind Circadian Anti Ischemia Program in Europe (CAPE Trial). J Am Coll Cardiol 1994;24:1460-1467.

176. Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO. Attenuation of the circadian patterns of myocardial ischemia with nifedifpine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992;19:1380-1386.

177. Davies RF, Habibi H, Klinke WP, et al. Effect of amlodipine, atenolol, and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. J Am Coll Cardiol 1995;25:619-625.

178. Jimenez AH, Tofler GH, Chen X, Stubbs ME, Solomon HS, Muller JE. Effects of nadolol on hemo-dynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension. Am J Cardiol 1993;72:47-52.

179. Andreotti F, Kluft C, Davies GJ, Huisman LG, deBart AC, Maseri A. Effect of propanolol (long acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1. Am J Cardiol 1991;68:1295-1299.

180. Shepherd JS, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.

181. Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.

182. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-785.

183. Rubins HB, Robins SJ, Collins D, et al. Gemfibrazol for the secondary prevention of coronary heart disease in the with low levels of high-density lipoprotein cholesterol: Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trail Study Group. N Engl J Med 1999;341:410-418.

184. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:356-362.

185. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1993;121:293-298.

186 Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612-628.

187. Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Change in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men and women. JAMA 1995;273:1093-1098.

188. Fletcher GF, Balady G, Blair SN, et al. Benefits and recommendations for physical activity programs for all Americans: a statement for health professionals by the committee on exercise and cardiac rehabilitation of the council on clincial cardiology, American Heart Association. Circulation 1996;94: 857-862.

189. Yusuf S. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation? Circulation 1995;92:1079-1082.

190. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA 1995;274:654-655.

191. Bertolet BD, Hill JA, Pepine CJ. Treatment strategies for daily life silent myocardial ischemia: a correlation with potential pathogenetic mechanisms. Prog Cardiovasc Dis 1992;35:97-118.

192. Flack JM, Yunis C. Therapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseases. J Hum Hypertens 1997;11:23-28.

193. Sica D. Lessons learned from prematurely terminated clinical trials. Curr Hypertension Reports 2001; 3:360-366.

194. Munger MA, Kenney JK. A chronobiologic approach to the pharmacotherapy of hypertension and angina. Ann Pharmacother 2000;34:1313-1319.

195. Kurnik PB. Practical implications of circadian variations in thrombolytic and thrombotic activities. Cardiol Clin 1996;14:251-262.

196. Braunwald E. Morning resistance to thrombolytic therapy. Circulation 1995;91:1604.

197. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1007;350:473-479.

198. Naghavi M, Madjid M, Khan MR, Mohammadi RM, Willerson JT, Casscells SW. New developments in the detection of vulnerable plaque. Curr Atheroscler Rep 2001;3:125-135.

199. Nissen S. Coronary angiography and intravascular ultrasound. Am J Cardiol 2001;87:15A-20A.

200. Brezinski ME, Tearney GJ, Bouma BE, et al. Optical coherence tomography for optical biopsy. Properties and demonstration of vascular pathology. Circulation 1996;93:1206-1213.

201. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-609.

202. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-938.

203. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996;347:1447-1451.

204. Stefanadis C, Diamantoupoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected invivo: a new method of detection by application of a special thermography catheter. Circulation 1999;99:1965-1971.

205. Konings MK, Mali WP, Viergever MA. Develoment of an intravascular impedance catheter for detection of fatty lesions in arteries. IEEE Trans Med Imaging 1997;16:439-446.

206. Cassis LA, Lodder RA. Near-IR imaging of atheromas in living arterial tissue. Anal Chem 1993;65: 1247-1256.

207. Dempsey RJ, Cassis LA, Davis DG, Lodder RA. Near-infrared imaging and spectroscopy in stroke research: lipoprotein distribution and disease. Ann NY Acad Sci 1997;820:149-169.

208. Jaross W, Neumeister V, Lattke P, Schuh D. Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy. Atherosclerosis 1999;147:327-337.

209. Cohen MC, Muller JE. Triggers of acute myocardial infarction. In: Gersh BJ, Rahimtoola SH, eds. Acute Myocardial Infarction. Elsevier, New York, 1996, pp. 91-105.

Was this article helpful?

0 0
Reducing Blood Pressure Naturally

Reducing Blood Pressure Naturally

Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.

Get My Free Ebook

Post a comment